Lipocalyx Enters R&D Agreement with BioNTech

Halle, Jan 24th, 2018. Lipocalyx, a leading developer of drug delivery systems for nucleic acids, has entered into a research and development agreement with BioNTech AG exclusive for certain fields. Under the agreement, Lipocalyx will apply its Viromer® technology for the delivery of certain mRNA’s and BioNTech will assume responsibility for the development of the [...]

By | 2018-01-24T11:47:22+00:00 January 24th, 2018|Allgemein|Comments Off on Lipocalyx Enters R&D Agreement with BioNTech